BD Reports Fourth Quarter and Full Year Fiscal 2022 Financial Results
Execution of BD 2025 Strategy Driving Consistent Durable Growth Q4 revenue from continuing operations of $4.8 billion decreased 1.8% as reported and increased...
Stay updated with breaking news from Embecta Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Execution of BD 2025 Strategy Driving Consistent Durable Growth Q4 revenue from continuing operations of $4.8 billion decreased 1.8% as reported and increased...
In this article, we will discuss the top 10 small-cap stocks in top investors' stock portfolio. If you want to skip our analysis, you can take a look at the list of Top Investors' Stock Portfolio: 5...
FREMONT, Calif. and PARSIPPANY, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Intuity Medical, Inc. and Embecta Corp. (“embecta”) (NASDAQ: EMBC) today...
FREMONT, Calif. and PARSIPPANY, N.J., Nov. 07, 2022 -- Intuity Medical, Inc. and Embecta Corp. today announced they have signed a co-promotional agreement under which embecta sales... | November 7, 2022
03.11.2022 - PARSIPPANY, N.J., Nov. 03, 2022 (GLOBE NEWSWIRE) - Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, will host a conference call to discuss its fiscal fourth quarter and full year 2022 ...